3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 9987446 |
| SCHEMBL ID | 487075 |
| MeSH ID | M0129648 |
| Synonym |
|---|
| 7207-68-3 |
| 5-fluoro-2'-deoxy-o',o'-dipalmitoyluridine |
| uridine, 2'-deoxy-5-fluoro-, 3',5'-dihexadecanoate |
| 3',5'-o-dipalmitoyl-5-fluoro-2'-deoxyuridine |
| 3,5-dipalmitoyl-fudr |
| 2'-deoxy-3',5'-di-o-palmitoyl-5-fluorouridine |
| BJLOKZVEONMGKJ-HKIDPNTFSA-N |
| SCHEMBL487075 |
| [(2r,3s,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3-hexadecanoyloxyoxolan-2-yl]methyl hexadecanoate |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.91) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||